Find-A-Study

Validation & Intervention Testing for Aging, Longevity and Healthspan (VITAL-H)

Lay Description

We are looking at whether two FDA-approved medications, semaglutide and dapagliflozin, may help people stay healthier as they age. Researchers want to learn if these medications can help maintain strength, physical function, and overall health in adults ages 60 to 75. The information collected will also help researchers better understand how aging affects the body over time.

Eligibility

Eligible Ages: 60-75
Eligible Genders: All
Accepts Healthy Volunteers: Yes

Inclusion Criteria

• Willing to follow the study intervention regimen as instructed (dapagliflozin, semaglutide or placebo)

• Currently live independently in the community (i.e., not in a nursing home, assisted living facility, or other institutional setting)

• Body Mass Index (BMI) between 20 and 40 kg/m²

Exclusion Criteria

Study Design

Arm Groups

Study Contact

Tiffany Cortes
210-450-8998
cortest@uthscsa.edu

Eloisa Martinez

martineze42@uthscsa.edu

Elena Volpi
210-562-6139
volpi@uthscsa.edu

Principal Investigator
Elena Volpi